Contents

Current Cancer Drug Targets, Volume 11 - Number 5

Post-Translational Modifications of PTEN and their Potential Therapeutic Implications

, 11(5): 536 - 547

G. Singh and A. M. Chan


DOI: 10.2174/156800911795655930




A Cross-Talk Between NFAT and NF-κB Pathways is Crucial for Nickel- Induced COX-2 Expression in Beas-2B Cells

, 11(5): 548 - 559

T. Cai, X. Li, J. Ding, W. Luo, J. Li and C. Huang


DOI: 10.2174/156800911795656001




Targeting Aldose Reductase for the Treatment of Cancer

, 11(5): 560 - 571

R. Tammali, S. K. Srivastava and K. V. Ramana


DOI: 10.2174/156800911795655958




CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis

, 11(5): 572 - 585

A. Serafino, M. Zonfrillo, F. Andreola, R. Psaila, L. Mercuri, N. Moroni, D. Renier, M. Campisi, C. Secchieri and P. Pierimarchi


DOI: 10.2174/156800911795655976




The Pro-Survival Function of Akt Kinase can be Overridden or Altered to Contribute to Induction of Apoptosis

, 11(5): 586 - 599

D. M. Benbrook and C. P. Masamha


DOI: 10.2174/156800911795655994




The Centrosome: A Target for Cancer Therapy

, 11(5): 600 - 612

M. Mazzorana, G. Montoya and G. B. Mortuza


DOI: 10.2174/156800911795655949




Drug Resistance: Challenges to Effective Therapy

, 11(5): 613 - 623

M. P.V. Shekhar


DOI: 10.2174/156800911795655921




VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future

, 11(5): 624 - 653

P. S. Sharma, R. Sharma and T. Tyagi


DOI: 10.2174/156800911795655985




Malignant Transformation of Mammary Epithelial Cells by Ectopic Overexpression of the Aryl Hydrocarbon Receptor

, 11(5): 654 - 669

J. Brooks and S. E. Eltom


DOI: 10.2174/156800911795655967




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science